Estrogen and the cardiovascular system

Anne A Knowlton, A. R. Lee

Research output: Contribution to journalArticle

125 Citations (Scopus)

Abstract

Estrogen is a potent steroid with pleiotropic effects, which have yet to be fully elucidated. Estrogen has both nuclear and non-nuclear effects. The rapid response to estrogen, which involves a membrane associated estrogen receptor(ER) and is protective, involves signaling through PI3K, Akt, and ERK 1/2. The nuclear response is much slower, as the ER-estrogen complex moves to the nucleus, where it functions as a transcription factor, both activating and repressing gene expression. Several different ERs regulate the specificity of response to estrogen, and appear to have specific effects in cardiac remodeling and the response to injury. However, much remains to be understood about the selectivity of these receptors and their specific effects on gene expression. Basic studies have demonstrated that estrogen treatment prevents apoptosis and necrosis of cardiac and endothelial cells. Estrogen also attenuates pathologic cardiac hypertrophy. Estrogen may have great benefit in aging as an anti-inflammatory agent. However, clinical investigations of estrogen have had mixed results, and not shown the clear-cut benefit of more basic investigations. This can be explained in part by differences in study design: in basic studies estrogen treatment was used immediately or shortly after ovariectomy, while in some key clinical trials, estrogen was given years after menopause. Further basic research into the underlying molecular mechanisms of estrogen's actions is essential to provide a better comprehension of the many properties of this powerful hormone.

Original languageEnglish (US)
Pages (from-to)54-70
Number of pages17
JournalPharmacology and Therapeutics
Volume135
Issue number1
DOIs
StatePublished - Jul 2012

Fingerprint

Cardiovascular System
Estrogens
Estrogen Receptors
Activating Transcription Factors
Gene Expression
Cardiomegaly
Ovariectomy
Menopause
Phosphatidylinositol 3-Kinases
Anti-Inflammatory Agents
Necrosis
Endothelial Cells
Steroids
Clinical Trials
Hormones
Apoptosis

Keywords

  • Aging
  • Cardiac hypertrophy
  • Cardiac myocyte
  • Cardiovascular
  • Endothelial
  • Estrogen
  • Heart failure
  • HRT
  • Inflammation
  • Menopause

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

Estrogen and the cardiovascular system. / Knowlton, Anne A; Lee, A. R.

In: Pharmacology and Therapeutics, Vol. 135, No. 1, 07.2012, p. 54-70.

Research output: Contribution to journalArticle

Knowlton, Anne A ; Lee, A. R. / Estrogen and the cardiovascular system. In: Pharmacology and Therapeutics. 2012 ; Vol. 135, No. 1. pp. 54-70.
@article{59794dc7650d47418fef6f9423ba6a52,
title = "Estrogen and the cardiovascular system",
abstract = "Estrogen is a potent steroid with pleiotropic effects, which have yet to be fully elucidated. Estrogen has both nuclear and non-nuclear effects. The rapid response to estrogen, which involves a membrane associated estrogen receptor(ER) and is protective, involves signaling through PI3K, Akt, and ERK 1/2. The nuclear response is much slower, as the ER-estrogen complex moves to the nucleus, where it functions as a transcription factor, both activating and repressing gene expression. Several different ERs regulate the specificity of response to estrogen, and appear to have specific effects in cardiac remodeling and the response to injury. However, much remains to be understood about the selectivity of these receptors and their specific effects on gene expression. Basic studies have demonstrated that estrogen treatment prevents apoptosis and necrosis of cardiac and endothelial cells. Estrogen also attenuates pathologic cardiac hypertrophy. Estrogen may have great benefit in aging as an anti-inflammatory agent. However, clinical investigations of estrogen have had mixed results, and not shown the clear-cut benefit of more basic investigations. This can be explained in part by differences in study design: in basic studies estrogen treatment was used immediately or shortly after ovariectomy, while in some key clinical trials, estrogen was given years after menopause. Further basic research into the underlying molecular mechanisms of estrogen's actions is essential to provide a better comprehension of the many properties of this powerful hormone.",
keywords = "Aging, Cardiac hypertrophy, Cardiac myocyte, Cardiovascular, Endothelial, Estrogen, Heart failure, HRT, Inflammation, Menopause",
author = "Knowlton, {Anne A} and Lee, {A. R.}",
year = "2012",
month = "7",
doi = "10.1016/j.pharmthera.2012.03.007",
language = "English (US)",
volume = "135",
pages = "54--70",
journal = "Pharmacology and Therapeutics",
issn = "0163-7258",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Estrogen and the cardiovascular system

AU - Knowlton, Anne A

AU - Lee, A. R.

PY - 2012/7

Y1 - 2012/7

N2 - Estrogen is a potent steroid with pleiotropic effects, which have yet to be fully elucidated. Estrogen has both nuclear and non-nuclear effects. The rapid response to estrogen, which involves a membrane associated estrogen receptor(ER) and is protective, involves signaling through PI3K, Akt, and ERK 1/2. The nuclear response is much slower, as the ER-estrogen complex moves to the nucleus, where it functions as a transcription factor, both activating and repressing gene expression. Several different ERs regulate the specificity of response to estrogen, and appear to have specific effects in cardiac remodeling and the response to injury. However, much remains to be understood about the selectivity of these receptors and their specific effects on gene expression. Basic studies have demonstrated that estrogen treatment prevents apoptosis and necrosis of cardiac and endothelial cells. Estrogen also attenuates pathologic cardiac hypertrophy. Estrogen may have great benefit in aging as an anti-inflammatory agent. However, clinical investigations of estrogen have had mixed results, and not shown the clear-cut benefit of more basic investigations. This can be explained in part by differences in study design: in basic studies estrogen treatment was used immediately or shortly after ovariectomy, while in some key clinical trials, estrogen was given years after menopause. Further basic research into the underlying molecular mechanisms of estrogen's actions is essential to provide a better comprehension of the many properties of this powerful hormone.

AB - Estrogen is a potent steroid with pleiotropic effects, which have yet to be fully elucidated. Estrogen has both nuclear and non-nuclear effects. The rapid response to estrogen, which involves a membrane associated estrogen receptor(ER) and is protective, involves signaling through PI3K, Akt, and ERK 1/2. The nuclear response is much slower, as the ER-estrogen complex moves to the nucleus, where it functions as a transcription factor, both activating and repressing gene expression. Several different ERs regulate the specificity of response to estrogen, and appear to have specific effects in cardiac remodeling and the response to injury. However, much remains to be understood about the selectivity of these receptors and their specific effects on gene expression. Basic studies have demonstrated that estrogen treatment prevents apoptosis and necrosis of cardiac and endothelial cells. Estrogen also attenuates pathologic cardiac hypertrophy. Estrogen may have great benefit in aging as an anti-inflammatory agent. However, clinical investigations of estrogen have had mixed results, and not shown the clear-cut benefit of more basic investigations. This can be explained in part by differences in study design: in basic studies estrogen treatment was used immediately or shortly after ovariectomy, while in some key clinical trials, estrogen was given years after menopause. Further basic research into the underlying molecular mechanisms of estrogen's actions is essential to provide a better comprehension of the many properties of this powerful hormone.

KW - Aging

KW - Cardiac hypertrophy

KW - Cardiac myocyte

KW - Cardiovascular

KW - Endothelial

KW - Estrogen

KW - Heart failure

KW - HRT

KW - Inflammation

KW - Menopause

UR - http://www.scopus.com/inward/record.url?scp=84861347494&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861347494&partnerID=8YFLogxK

U2 - 10.1016/j.pharmthera.2012.03.007

DO - 10.1016/j.pharmthera.2012.03.007

M3 - Article

C2 - 22484805

AN - SCOPUS:84861347494

VL - 135

SP - 54

EP - 70

JO - Pharmacology and Therapeutics

JF - Pharmacology and Therapeutics

SN - 0163-7258

IS - 1

ER -